Gedeon Richter

RICHTER

HU0000123096

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 15:59:41 17/07/2024 BST			5-day change	1st Jan Change
9,745 ^HUF	0.00%		+1.56%	+11.37%

06-28	Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. commences an Equity Buyback Plan for 18,637,486 shares, representing 10% of its issued share capital, under the authorization approved on April 25, 2024.	CI
06-19	Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired BCI Pharma SA for an enterprise value of ?12 million.	CI

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired remaining 50% stake in Gedeon Richter Rxmidas Joint Venture Co. Ltd. from Rxmidas Pharmaceuticals Co, Ltd.

January 21, 2016

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) acquired remaining 50% stake in Gedeon Richter Rxmidas Joint Venture Co. Ltd. from Rxmidas Pharmaceuticals Co, Ltd. on January 22, 2016.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) completed the acquisition of remaining 50% stake in Gedeon Richter Rxmidas Joint Venture Co. Ltd. from Rxmidas Pharmaceuticals Co, Ltd. on January 22, 2016.

Latest news about Gedeon Richter

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. commences an Equity Buyback Plan for 18,637,486 shares, representing 10% of its issued share capital, under the authorization approved on April 25, 2024.	06-28	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired BCI Pharma SA for an enterprise value of ?12 million.	06-18	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired Specific assets from Mithra Recherche Et Développement Sa.	06-10	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired Neuralis and Estetra from Mithra Pharmaceuticals SA.	06-10	CI
Gedeon Richter Plc. Approves Dividend Payment in Respect of the 2023 Financial Year	05-31	CI
Gedeon Richter plc announces Directorate Changes	05-22	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s Equity Buyback announced on April 4, 2023, has expired.	04-02	CI
Gedeon Richter Plc. Proposes Dividend	03-25	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Transcript : Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., Q4 2023 Earnings Call, Feb 29, 2024	02-29
Gedeon Richter plc announces Board Changes, Effective 1 March 2024	02-26	CI
Formycon Sells 9% Interest to Gedeon Richter for EUR83 Million	01-30	MT
GRANATA BIO Corp announced that it has received $14 million in funding from GV Management Company, LLC, CooperSurgical, Inc., Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., Alumni Ventures Group, LLC, Vibe Biotechnology Inc., Amboy Street Ventures and other investors.	01-15	CI
Mithra Signs Agreement with Gedeon Richter for Commercialization of Estelle, Donesta in China	12-04	MT
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08	CI
Transcript : Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., Q3 2023 Earnings Call, Nov 08, 2023	11-08
Gedeon Richter Plc., Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH Receives European Commission grant for Commercialisation of RYEQO®	11-02	CI
European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis	11-02	CI
GRANATA BIO Corp announced that it expects to receive $15.590561 million in funding	19/10/23	CI
Gedeon Richter and Sumitomo Pharma Receives Positive Chmp Opinion for Ryeqo(R) for Treatment of Endometriosis	15/09/23	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23	CI
Transcript : Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt., Q2 2023 Earnings Call, Aug 04, 2023	04/08/23
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. entered into an agreement to acquire Giskit MD B.V from Giskit Holding B.V. for ?30 million.	19/07/23	CI

Chart Gedeon Richter

Duration

Period

More charts

Company Profile

Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Companyâs business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Companyâs core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Companyâs subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.

Sector

Pharmaceuticals

Calendar

05/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Gedeon Richter

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9,790 HUF

Average target price

11,800 HUF

Spread / Average Target

+20.53%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GEDEON RICHTER	+11.37%	4.97B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+25.40%	45.35B
OTSUKA HOLDINGS CO., LTD.	+38.38%	24.34B
SANDOZ GROUP AG	+27.09%	16.51B
CIPLA LIMITED	+21.19%	14.6B
ZYDUS LIFESCIENCES LIMITED	+71.91%	14.27B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.63%	6.57B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.08%	5.76B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals

Gedeon Richter

Equities

RICHTER

HU0000123096

Pharmaceuticals

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired remaining 50% stake in Gedeon Richter Rxmidas Joint Venture Co. Ltd. from Rxmidas Pharmaceuticals Co, Ltd.

Latest news about Gedeon Richter

Chart Gedeon Richter

Company Profile

Income Statement Evolution

Ratings for Gedeon Richter

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Generic Pharmaceuticals